July 19, 2024 Biodexa Pharmaceuticals PLC Announces Pricing of $5.0 Million Registered Direct Offering and Concurrent Private Placement Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) (Nasdaq: BDRX), an acquisition-focused clinical… Read More »Announces Pricing of $5.0 Million Registered Direct Offering and Concurrent Private Placement
In an era where businesses rely heavily on digital technologies, the significance of Information Technology (IT) audits cannot be overstated. As the backbone of organizational operations, IT systems and infrastructure… Read More »What Happens During An IT Audit
The future of data is the universal data lakehouse. Image created with DALL·E We’re excited to announce that Craft led the $35M Series B round in Onehouse, the universal data lakehouse… Read More »Why We Invested in Onehouse
Whether they have worked in the healthcare industry or not, most understand the sensitivity and importance of the patient information that is stored by healthcare groups and systems. Healthcare providers… Read More »Healthcare and Ransomware
May 22, 2024 Biodexa Pharmaceuticals PLC(“Biodexa” or the “Company”) Biodexa Announces $7 Million of Gross Proceeds from Warrant Exercises Proceeds Cover Year 1 eRapa Phase 3 Obligations, Unlocking Twice that… Read More »Biodexa Announces $7 Million of Gross Proceeds from Warrant Exercises
May 15, 2024 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) Posting of Annual Report & Notice of AGM Total Voting Rights Biodexa Pharmaceuticals PLC (NASDAQ: BDRX), a clinical stage biopharmaceutical… Read More »Posting of Annual Report & Notice of AGM – Total Voting Rights
